CAMP4 Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CAMP and other ETFs, options, and stocks.

About CAMP

CAMP4 Therapeutics Corp. operates as a biotechnology company which engages in the discovery of treatment options for patients. The company was founded by Richard A. 

CEO
Josh Mandel-Brehm
CEOJosh Mandel-Brehm
Employees
55
Employees55
Headquarters
Cambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded
2015
Founded2015
Employees
55
Employees55

CAMP Key Statistics

Market cap
333.79M
Market cap333.79M
Price-Earnings ratio
-2.91
Price-Earnings ratio-2.91
Dividend yield
Dividend yield
Average volume
287.63K
Average volume287.63K
High today
$7.29
High today$7.29
Low today
$6.68
Low today$6.68
Open price
$6.87
Open price$6.87
Volume
580.61K
Volume580.61K
52 Week high
$7.69
52 Week high$7.69
52 Week low
$1.31
52 Week low$1.31

Stock Snapshot

The current CAMP4 Therapeutics(CAMP) stock price is $7.13, with a market capitalization of 333.79M. The stock trades at a price-to-earnings (P/E) ratio of -2.91.

As of 2025-12-17, CAMP4 Therapeutics(CAMP) stock has fluctuated between $6.68 and $7.29. The current price stands at $7.13, placing the stock +6.7% above today's low and -2.2% off the high.

CAMP4 Therapeutics(CAMP) shares are trading with a volume of 580.61K, against a daily average of 287.63K.

During the past year, CAMP4 Therapeutics(CAMP) stock moved between $1.31 at its lowest and $7.69 at its peak.

During the past year, CAMP4 Therapeutics(CAMP) stock moved between $1.31 at its lowest and $7.69 at its peak.

Analyst ratings

83%

of 6 ratings
Buy
83.3%
Hold
16.7%
Sell
0%

People also own

Based on the portfolios of people who own CAMP. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.